Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries

Summary

The objective of this pilot study is to evaluate the efficacy and safety of preoperative administration of levosimendan in patients with chronic heart failure scheduled for major abdominal cancer surgery assuming the reduction of both perioperative morbidity and mortality.

Timeline

Start

2017-08-01

Primary completion

2018-02-01

Completion

2018-04-23

Drugs

Indications